tively). Sinonasal culture results were also recorded. Any pretransplant medical or surgical intervention was noted, as was any posttransplant sinonasal complication and subsequent intervention. Correlation between pretransplant findings and subsequent sinonasal disease was analyzed. RESULTS: Eight-two patients underwent pretransplant evaluation. 53% of patients were asymptomatic at time of evaluation, while 16% complained of rhinorrhea, 8% of nasal congestion, and 6% of facial pressure. 24 of 82 patients (29.3%) underwent CT imaging, with an average Lund-Mackay score of 2.2 out of 28. 82 of 82 patients (100%) underwent endoscopic evaluation, with a mean endoscopic grading score of 0.6 out of 20. Of 42 culture specimens, 30 grew coagulase-negative Staphylococcus, 7 grew Corynebacterium, 7 grew Staphylococcus Aureus, and 5 grew Streptococcus Viridans. 4 of 82 patients (4.9%) had evidence of rhinosinusitis on evaluation, three of which underwent endoscopic surgery and one of which was treated with antibiotic and oral steroids. None of these patients developed subsequent sinonasal complications following transplantation. 5 of 82 patients (6.1%) were evaluated for sinonasal symptoms following transplantation. One was treated for uncomplicated acute sinusitis. Only one required surgery for a complicated acute sinusitis. The overall incidence of acute or chronic invasive fungal sinusitis was 0%. CONCLUSION: Pretransplant imaging, endoscopy, and culture results are not predictive of subsequent sinonasal complications during hematopoietic cell transplantation. All patients who underwent pretransplant medical or surgical intervention had AAOHNS/SAHP criteria for sinusitis elicited during a routine medical interview. Furthermore, the two patients who did develop sinonasal disease following transplantation had no evidence of disease during pretransplant evaluation. Studies are costly, time-consuming, potentially harmful, and of limited utility in absence of symptoms. Therefore, a standard history and physical examination should be sufficient in the pretransplant setting, and patients with symptoms of sinusitis should be referred to an otolaryngologist for further work-up and management.
Sinus Headaches and Response to Sodium Valperoate
Mohammad Hossein Dadgarnia, MD (presenter); Saeid Atighechi, MD; Mohammad Hossein Baradaranfar, MD OBJECTIVE: To evaluate the patients who have sinus headaches, either self-ascribed or physician-diagnosed, and to determinate the efficacy of sodium valproate in a prophylactic treatment of the patients without positive sinonasal findings. METHOD: One hundred four patients with "sinus headaches" were evaluated prospectively in the Yazd Khatamol-Anbia clinic from May 2007 to November 2008. The patients with a normal rigid nasal endoscopy and paranasal sinus computed tomography scan were treated with sodium valproate as a prophylactic treatment. After a 3-month follow-up, the patients' response to the treatment was evaluated with Wilcoxon test. RESULTS: Seventy two patients (69.2%) didn't have any positive sino-nasal findings in the nasal endoscopy and the computed tomography scanning. The response rate to the treatment for these patients was as follows: significant improvement in 44 patients (61.1%), partial response in (9.7%), no response in (15.3%), and ten patients (13.9%) withdrew or failed to follow-up. According to Wilcoxon test, the patients' response rate to sodium valproate was statistically significant (Pϭ0.001). CONCLUSION: A majority of "sinus headache" patients do not show any positive sino-nasal pathologic findings. Therefore, we have to consider migraine headache as a considerable cause and sodium valproate as an effective prophylactic treatment in patients with sinus headache.
Sphenopalatine Artery Ligation: A Cadaver Anatomic Study
Courtney Shires, MD (presenter); Merry Sebelik, MD; John Boughter, PhD OBJECTIVE: 1) Clarify endoscopic anatomy of the sphenopalatine artery within the posterior nasal cavity with objective measurements in relation to the most readily visible and noninvasive landmarks, utilizing a human cadaver model. 2) Simplify surgical approach to sphenopalatine artery ligation to minimize mucosal trauma in treatment of refractory posterior epistaxis in the often medically fragile and/or coagulopathic patient. METHOD: Data was collected from 50 human cadaveric sagitally sectioned heads (21 female, 29 male) from November to December 2009 in the University of Tennessee anatomy lab. Using the zero degree endoscope, an L-shaped incision was made in the lateral nasal wall 1 cm anterior to the posteriormost attachment of the middle turbinate. The mucosa of the lateral nasal wall was elevated until the crista ethmoidalis and the sphenopalatine artery (SPA) were located. In those nasal cavities in which the transnasal approach was unsuccessful, a maxillary antrostomy was carried out posteriorly until the posterior extent of the maxillary antrum was reached, thus providing a landmark for the SPA foramen. The number of nasal cavities in which the transnasal approach successfully revealed the SPA foramen was compared to those which required maxillary antrostomy. Once the SPA foramen was successfully located and SPA ligation carried out, a direct measurement of the distance from the posterior edge of the maxillary natural ostium to the anterior edge of the SPA foramen was carried out. RESULTS: Successful ligation of the SPA via the lateral nasal wall incision was achieved in 45 of 50 specimens (90%). In all specimens in which the lateral nasal wall approach was unsuccessful, the SPA was located after performing a maxillary
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